Novo Nordisk A/S (NVO) Steps Up Research to Find Cure for Diabetes, Plans to Hire More Researchers
5/7/2012 8:23:19 AM
About 3 million Americans have Type 1 diabetes, which can be treated with daily shots of insulin but can't be cured. A big player in diabetes, Danish drug company Novo Nordisk, is expanding its research efforts in Seattle in hopes of making progress toward a cure. The company already employs 71 people at the Seattle research center on inflammatory diseases it opened in 2009. Next month it will launch a diabetes-research effort here, led by Dr. Matthias von Herrath, director of the nonprofit Center for Type 1 Diabetes Research in La Jolla, California. It's set to open June 14 in Novo Nordisk's facilities in South Lake Union.
comments powered by